We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 359

SCOTUS sides with FTC in reverse payment deals

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

A divided U.S. Supreme Court has determined that patent-infringement settlement agreements requiring the patentee to pay the claimed infringer

Pharmacy and hospital interests present comments on proposed compounding bill

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

Proposed legislation (S. 959) that would give the U.S. Food and Drug Administration (FDA) the authority to oversee compounding pharmacies that ship

Lab Trade Association presses FDA on plan to regulate laboratory developed tests

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

The American Clinical Laboratory Association (ACLA) has submitted a citizen petition to the Food and Drug Administration (FDA), asking the agency to

Neumedicines receives $8.3 million from BARDA for radiation sickness drug

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

Pasadena-based Neumedicines Inc. has reportedly received $8.3 million from the Biomedical Advanced Research & Development Authority (BARDA) of the U

U.S. Supreme Court issues ruling on patentability of human genes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

The U.S. Supreme Court has determined that while human genes and the information they encode are not patent eligible, despite the effort required to

Biopharmaceutical companies have 215 heart diseasestroke drugs in R&D pipeline

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

According to a new Pharmaceutical Research and Manufacturers of America (PhRMA) report, U.S. biopharmaceutical companies have 215 medicines under

FDA seeks comments on de-identified and masked data

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

The U.S. Food and Drug Administration (FDA) has issued a notice seeking comments on "the proposed availability of de-identified and masked data

Biotech set to raise $86 million in IPO to support cancer and IEM products

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

Agios Pharmaceuticals, Inc. has filed a registration statement with the U.S. Securities and Exchange Commission indicating its intent to raise up to

News Bytes - June 6, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

The U.S. Patent and Trademark Office creates the After Final Consideration Pilot Program 2.0 which modifies and extends a program designed to

FDA seeks premarket notification for mobile medical application

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

The U.S. Food and Drug Administration (FDA) has informed an India-based company that it is expected to file a premarket notification as to its uChek